PT  - JOURNAL ARTICLE
AU  - Tawbi, Hussein A
AU  - Robert, Caroline
AU  - Brase, Jan C
AU  - Gusenleitner, Daniel
AU  - Gasal, Eduard
AU  - Garrett, James
AU  - Savchenko, Alexander
AU  - Görgün, Güllü
AU  - Flaherty, Keith T
AU  - Ribas, Antoni
AU  - Dummer, Reinhard
AU  - Schadendorf, Dirk
AU  - Long, Georgina V
AU  - Nathan, Paul D
AU  - Ascierto, Paolo A
TI  - Spartalizumab or placebo in combination with dabrafenib and trametinib in patients with <em>BRAF</em> V600-mutant melanoma: exploratory biomarker analyses from a randomized phase 3 trial (COMBI-i)
AID  - 10.1136/jitc-2021-004226
DP  - 2022 Jun 01
TA  - Journal for ImmunoTherapy of Cancer
PG  - e004226
VI  - 10
IP  - 6
4099  - http://jitc.bmj.com/content/10/6/e004226.short
4100  - http://jitc.bmj.com/content/10/6/e004226.full
SO  - J Immunother Cancer2022 Jun 01; 10
AB  - Markup server — Error Not Found The page you were trying to reach could not be found. Please check the address for the page you were trying to reach. If you believe you have reached this page in error, you may contact us with any questions.